Samarkand wins 3-year contract extension with beauty brand Templespa

(Alliance News) - Samarkand Group PLC announced on Monday that it signed a three-year contract ...

Alliance News 18 January, 2022 | 8:37AM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - Samarkand Group PLC announced on Monday that it signed a three-year contract extension with Templespa Ltd, a Sussex, England-based skincare and beauty product company.

Samarkand is a London-based e-commerce company focused getting Western brands to the Chinese market. It said Templespa has been one of its brand partners since 2019.

The agreement includes distribution services and an expansion of its storefront offering for Chinese e-commerce platforms, including a Tmall Global flagship store planned for the second quarter of 2022.

Tmall Global is a Chinese e-commerce platform that allows brands and retailers without operations in China to build virtual storefronts and ship products into China. Samarkand said that Tmall Global generated approximately GBP360 billion gross merchandise value in 2020.

Chief Executive David Hampstead said: "We are very pleased to be expanding our work with Templespa, who we've worked closely with since 2019. The Chinese e-commerce market is notoriously difficult to penetrate and being awarded this contract extension reflects our expertise and extensive experience in helping leading beauty brands grow in China."

Samarkand was last quoted on Aquis Stock Exchange at 155 pence. The stock was quoted at 134p on March 22 last year.

By Heather Rydings; heatherrydings@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Samarkand Group PLC

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures